Company news

Protara Therapeutics, Inc. news in 2021

Protara Therapeutics, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Protara Therapeutics Announces Third Quarter 2021 Financial Results and Business Overview

November 3, 2021

Protara Therapeutics Announces FDA Clearance of Investigational New Drug Application for TARA-002 for the Treatment of Non-Muscle Invasive Bladder Cancer

October 11, 2021

Protara Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

September 16, 2021

Protara Therapeutics Announces Results from a Retrospective Study Evaluating the Prevalence of Cholestasis in Patients Dependent on Parenteral Nutrition

September 12, 2021

Protara Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

September 6, 2021

Protara Therapeutics Announces Second Quarter 2021 Financial Results and Business Overview

August 4, 2021

Protara Therapeutics to Present at the Ladenburg Thalmann Healthcare Conference

July 6, 2021

Protara Therapeutics Announces Appointment of Jane Huang, M.D. to Board of Directors

June 9, 2021

Protara Therapeutics to Participate in Upcoming Virtual Investor Conferences

May 12, 2021

Protara Therapeutics Announces First Quarter 2021 Financial Results and Business Overview

May 5, 2021

Protara Therapeutics Provides Regulatory Update for TARA-002 for the Treatment of Lymphatic Malformations

April 22, 2021

Protara Therapeutics Announces Appointment of Martín Sebastian Olivo, M.D. as Chief Medical Officer

April 18, 2021

Protara Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Business Overview

March 10, 2021

Protara Therapeutics Announces Appointment of Cynthia Smith to Board of Directors

February 1, 2021

Decks in 2021